Novo Holdings will acquire an approximately 60% controlling stake in Singe Use Support, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital.
Related Posts
Asahi Kasei Develop Novel Membrane System to Dehydrate Organic Solvents Without Heat or Pressure
Asahi Kasei has developed a novel membrane system for dehydrating organic solvents for pharmaceutical applications without the application of heat…
Zuellig Pharma Acquires Cialis and Alimta from Lilly
Zuellig Pharma has announced that it has completed the acquisition of two brands, Cialis (Tadalafil) and Alimta (Pemetrexed), from Eli Lilly and Company for…
Upperton Pharma Open New Development and GMP Manufacturing Facility
UK-based contract development and manufacturing organisation Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech…